Indication
Hyperphagia in Prader-Willi syndrome
Hyperphagia in Prader-Willi syndrome is a severe, hallmark neurobehavioral manifestation of a rare neurodevelopmental genetic disorder resulting from the loss of paternally expressed genes in chromosome region 15q11.2–q13. Read more about Hyperphagia in Prader-Willi syndrome
1 drugs 1 manufacturers
Drugs that treat it
Common Hyperphagia in Prader-Willi syndrome therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonHyperphagia in Prader-Willi syndrome is a severe, hallmark neurobehavioral manifestation of a rare neurodevelopmental genetic disorder resulting from the loss of paternally expressed genes in chromosome region 15q11.2–q13.
It primarily affects the neuroendocrine and metabolic systems across pediatric and adult populations, emerging typically after an initial infantile phase of hypotonia and poor feeding.
Pathophysiologically driven by hypothalamic dysfunction—including disrupted signaling pathways regulating satiety and prolonged elevations in orexigenic hormones such as ghrelin—the condition is characterized by an insatiable hunger, profound lack of normal fullness, persistent food preoccupation, and compulsive food-seeking behaviors.
Without external environmental restrictions, this unrelenting drive to eat leads to rapid-onset hyperphagic obesity and life-threatening metabolic and cardiopulmonary complications.
- nih.gov
Hyperphagia in Prader-Willi syndrome is a severe, hallmark neurobehavioral manifestation of a rare neurodevelopmental genetic disorder resulting from the loss of paternally expressed genes in chromosome region 15q11.2–q13 Without external environmental restrictions, this unrelenting drive to eat leads to rapid-onset hyperphagic obesity and life-threatening metabolic and cardiopulmonary complications
- medlineplus.gov
It primarily affects the neuroendocrine and metabolic systems across pediatric and adult populations, emerging typically after an initial infantile phase of hypotonia and poor feeding Without external environmental restrictions, this unrelenting drive to eat leads to rapid-onset hyperphagic obesity and life-threatening metabolic and cardiopulmonary complications
- nih.gov
It primarily affects the neuroendocrine and metabolic systems across pediatric and adult populations, emerging typically after an initial infantile phase of hypotonia and poor feeding
- fpwr.org
Pathophysiologically driven by hypothalamic dysfunction—including disrupted signaling pathways regulating satiety and prolonged elevations in orexigenic hormones such as ghrelin—the condition is characterized by an insatiable hunger, profound lack of normal fullness, persistent food preoccupation, and compulsive food-seeking behaviors Without external environmental restrictions, this unrelenting drive to eat leads to rapid-onset hyperphagic obesity and life-threatening metabolic and cardiopulmon...
- nih.gov
Pathophysiologically driven by hypothalamic dysfunction—including disrupted signaling pathways regulating satiety and prolonged elevations in orexigenic hormones such as ghrelin—the condition is characterized by an insatiable hunger, profound lack of normal fullness, persistent food preoccupation, and compulsive food-seeking behaviors
- e-emj.org
Pathophysiologically driven by hypothalamic dysfunction—including disrupted signaling pathways regulating satiety and prolonged elevations in orexigenic hormones such as ghrelin—the condition is characterized by an insatiable hunger, profound lack of normal fullness, persistent food preoccupation, and compulsive food-seeking behaviors
Personalize your experience
Follow Hyperphagia in Prader-Willi syndrome and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.